A. DiLuigi

发表

Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.

L. Engmann, D. Griffin, J. Nulsen, 2015, Fertility and sterility.

Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

L. Engmann, D. Grow, D. Griffin, 2019, Journal of Ovarian Research.

The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS

D. Griffin, J. Nulsen, C. Benadiva, 2017, Contemporary clinical trials communications.

Effects of Gonadotropin‐Releasing Hormone Agonists And Antagonists on Luteal Function

J. Nulsen, A. DiLuigi, 2008 .

Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function

J. Nulsen, A. DiLuigi, 2007, Current opinion in obstetrics & gynecology.

Meiotic Arrest in Human Oocytes Is Maintained by a Gs Signaling Pathway1

L. Mehlmann, Margaret C. Pace, Vanessa N. Weitzman, 2008, Biology of reproduction.

Fallopian Tube Abnormalities and Associated Surgical Interventions

A. DiLuigi, C. Morosky, C. Bartels, 2015 .

Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.

L. Engmann, J. Nulsen, C. Benadiva, 2011, Journal of reproductive medicine.

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.

J. Nulsen, C. Benadiva, A. DiLuigi, 2008, Fertility and sterility.

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.

L. Engmann, J. Nulsen, C. Benadiva, 2010, Fertility and sterility.

Prevention of recurrent adnexal torsion.

Vanessa N. Weitzman, J. Nulsen, A. DiLuigi, 2008, Fertility and sterility.

Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles.

D. Grow, C. Bartels, J. Nulsen, 2020, Human reproduction.

Factors Associated With Increased Charges for Hysterectomy

J. Peipert, R. Jamshidi, K. Matteson, 2006, Obstetrics and gynecology.

Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.

Vanessa N. Weitzman, J. Nulsen, C. Benadiva, 2009, Fertility and sterility.

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.

J. Nulsen, C. Benadiva, A. DiLuigi, 2008, Fertility and sterility.

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.

J. Nulsen, C. Benadiva, A. DiLuigi, 2011, Fertility and sterility.

Prophylactic antibiotic administration prior to hysterectomy: a quality improvement initiative.

J. Peipert, S. Weitzen, R. Jamshidi, 2004, The Journal of reproductive medicine.